Translational Model‐Informed Dose Selection for Iruplinalkib, a Selective Oral ALK / ROS1 Tyrosine Kinase Inhibitor

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Guihong Yang, Yimei Wang, Huimin Zhao, Qingmei Zheng, Xinmei Wang, Linchao Jia, Qianqian Xin, Cuicui Ma, Yongpeng Zhang, Shansong Zheng, Xiaoyan Kang
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical and Translational Science
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items